313 related articles for article (PubMed ID: 32398026)
1. Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.
Har-Noy M; Or R
J Transl Med; 2020 May; 18(1):196. PubMed ID: 32398026
[TBL] [Abstract][Full Text] [Related]
2. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
3. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
Palatnik-de-Sousa CB
Front Immunol; 2020; 11():2173. PubMed ID: 32983183
[No Abstract] [Full Text] [Related]
4. Rapid COVID-19 vaccine development.
Graham BS
Science; 2020 May; 368(6494):945-946. PubMed ID: 32385100
[No Abstract] [Full Text] [Related]
5. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
Front Immunol; 2020; 11():1748. PubMed ID: 32849623
[TBL] [Abstract][Full Text] [Related]
6. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
Alsulaiman JW; Khasawneh AI; Kheirallah KA
J Infect Dev Ctries; 2020 Sep; 14(9):957-962. PubMed ID: 33031080
[TBL] [Abstract][Full Text] [Related]
7. Vaccine designers take first shots at COVID-19.
Cohen J
Science; 2020 Apr; 368(6486):14-16. PubMed ID: 32241928
[No Abstract] [Full Text] [Related]
8. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using
Zayed H
Front Immunol; 2020; 11():2051. PubMed ID: 32922408
[No Abstract] [Full Text] [Related]
9. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
[TBL] [Abstract][Full Text] [Related]
10. Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung.
Förster R; Fleige H; Sutter G
Front Immunol; 2020; 11():1959. PubMed ID: 32849655
[TBL] [Abstract][Full Text] [Related]
11. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(697):1220-1221. PubMed ID: 32520467
[No Abstract] [Full Text] [Related]
12. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.
Flanagan KL; Best E; Crawford NW; Giles M; Koirala A; Macartney K; Russell F; Teh BW; Wen SC
Front Immunol; 2020; 11():579250. PubMed ID: 33123165
[TBL] [Abstract][Full Text] [Related]
13. Rational Vaccine Design in the Time of COVID-19.
Burton DR; Walker LM
Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
[TBL] [Abstract][Full Text] [Related]
14. Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2.
Konwarh R
Front Immunol; 2020; 11():1531. PubMed ID: 32655584
[No Abstract] [Full Text] [Related]
15. COVID-19 vaccine BNT162b1 elicits human antibody and T
Sahin U; Muik A; Derhovanessian E; Vogler I; Kranz LM; Vormehr M; Baum A; Pascal K; Quandt J; Maurus D; Brachtendorf S; Lörks V; Sikorski J; Hilker R; Becker D; Eller AK; Grützner J; Boesler C; Rosenbaum C; Kühnle MC; Luxemburger U; Kemmer-Brück A; Langer D; Bexon M; Bolte S; Karikó K; Palanche T; Fischer B; Schultz A; Shi PY; Fontes-Garfias C; Perez JL; Swanson KA; Loschko J; Scully IL; Cutler M; Kalina W; Kyratsous CA; Cooper D; Dormitzer PR; Jansen KU; Türeci Ö
Nature; 2020 Oct; 586(7830):594-599. PubMed ID: 32998157
[TBL] [Abstract][Full Text] [Related]
16. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
Ietto G
Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
[TBL] [Abstract][Full Text] [Related]
17. Coronavirus vaccines get a biotech boost.
Dance A
Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
[No Abstract] [Full Text] [Related]
18. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
19. Status of COVID-19 vaccine development.
Taxt AM; Grødeland G; Lind A; Müller F
Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
[TBL] [Abstract][Full Text] [Related]
20. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B
Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
